Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The newly relaunched Acute Multidisciplinary Imaging and Interventional Centre (AMIIC) at the Radcliffe Department of Medicine welcomes its first NHS patients today, Monday 4 July.

AMIIC’s new photon counting CT scanner is the first in the world to sit within a hybrid catheterisation laboratory, and it overcomes the loss of information in conventional CT scans, resulting in clearer images for clinicians.

Patients at the Oxford University Hospitals NHS Foundation Trust will be the first to benefit from this new scanner, which is based at the John Radcliffe Hospital. Signs of cardiac disease can be quickly picked up in patients referred to AMIIC with chest pain or shortness of breath.

“We are looking forward to welcoming our first patients”, says Clinical Operations Manager Sheena Thomas.

AMIIC has a research as well as clinical role, and AMIIC Director Professor Charis Antoniades said, “Our new scanner has the potential to transform clinical practice, as well optimising artificial intelligence models at the big data facility, also within AMIIC.

Find out more about AMIIC

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’